Möchten Sie immer auf dem neuesten Stand bleiben?

CALGARY, Alberta, July 30, 2026 (GLOBE NEWSWIRE) -- Earlier this week, the Government of Alberta announced plans to allow patients to self-refer and pay privately for selected diagnostic imaging...

LONDON, July 23, 2026 (GLOBE NEWSWIRE) -- Affidea, the pan-European provider of community-based clinics, advanced diagnostics, and specialist private healthcare services, today announces a strategic...

TORONTO, July 15, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that its MRI-guided, AI-powered, Robotically-Driven and...

Oxford Brain Diagnostics Advances Vision for Measuring Brain Health and Neurodegenerative Disease with Five New Studies at AAIC 2026

Ulm, Germany, June 16, 2026 (GLOBE NEWSWIRE) -- NVision Quantum Technologies, a quantum technology company developing quantum systems for healthcare and life sciences, today announced that it has...

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) --  Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative...

The Jack & Sylvia Gin Emergency & Trauma Imaging Centre, known as GinETIC, was unveiled by Royal Columbian Hospital Foundation.

TORONTO, April 16, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...

TORONTO, April 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...